Evidence map›Paper›PMID 26045981›Full record

ArticleAmerican journal of cancer research2015

Status of epigenetic chromatin modification enzymes and esophageal squamous cell carcinoma risk in northeast Indian population.

Virendra Singh, Laishram C Singh, Avninder P Singh, Jagannath Sharma, Bibhuti B Borthakur, Arundhati Debnath, Avdhesh K Rai, Rup K Phukan, Jagadish Mahanta, Amal C Kataki and 2 more

Open access · greenAbstract read
In one paragraph

Article in American journal of cancer research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Virendra SinghNational Institute of Pathology (Indian Council of Medical Research) New Delhi-110029, India.
Laishram C SinghNational Institute of Pathology (Indian Council of Medical Research) New Delhi-110029, India.
Avninder P SinghNational Institute of Pathology (Indian Council of Medical Research) New Delhi-110029, India.
Jagannath SharmaB Borooah Cancer Institute (BBCI) Guwahati-781016, Assam, India.
Bibhuti B BorthakurB Borooah Cancer Institute (BBCI) Guwahati-781016, Assam, India.
Arundhati DebnathB Borooah Cancer Institute (BBCI) Guwahati-781016, Assam, India.
Avdhesh K RaiB Borooah Cancer Institute (BBCI) Guwahati-781016, Assam, India.
Rup K PhukanRegional Medical Research Centre (RMRC) Dibrugadh-786001, Assam, India.
Jagadish MahantaRegional Medical Research Centre (RMRC) Dibrugadh-786001, Assam, India.
Amal C KatakiB Borooah Cancer Institute (BBCI) Guwahati-781016, Assam, India.
Sujala KapurNational Institute of Pathology (Indian Council of Medical Research) New Delhi-110029, India.
Sunita SaxenaNational Institute of Pathology (Indian Council of Medical Research) New Delhi-110029, India.
Indian Council of Medical Research · INNational Institute of Pathology · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Esophageal cancer incidence is reported in high frequency in northeast India. The etiology is different from other population at India due to wide variations in dietary habits or nutritional factors, tobacco/betel quid chewing and alcohol habits. Since DNA methylation, histone modification and miRNA-mediated epigenetic processes alter the gene expression, the involvement of these processes might be useful to find out epigenetic markers of esophageal cancer risk in northeast Indian population. The present investigation was aimed to carryout differential expression profiling of chromatin modification enzymes in tumor and normal tissue collected from esophageal squamous cell carcinoma (ESCC) patients. Differential mRNA expression profiling and their validation was done by quantitative real time PCR and tissue microarray respectively. Univariate and multiple logistic regression analysis were used to analyze the epidemiological data. mRNA expression data was analyzed by Student t-test. Fisher exact test was used for tissue microarray data analysis. Higher expression of enzymes regulating methylation (DOT1L and PRMT1) and acetylation (KAT7, KAT8, KAT2A and KAT6A) of histone was found associated with ESCC risk. Tissue microarray done in independent cohort of 75 patients revealed higher nuclear protein expression of KAT8 and PRMT1 in tumor similar to mRNA expression. Expression status of PRMT1 and KAT8 was found declined as we move from low grade to high grade tumor. Betel nut chewing, alcohol drinking and dried fish intake were significantly associated with increased risk of esophageal cancer among the study subject. Study suggests the association of PRMT1 and KAT8 with esophageal cancer risk and its involvement in the transition process of low to high grade tumor formation. The study exposes the differential status of chromatin modification enzymes between tumor and normal tissue and points out that relaxed state of chromatin facilitates more transcriptionally active genome in esophageal carcinogenesis.

Indexed as

Esophageal cancerHDAChistone modification enzymesKAT8PRMT1tissue-microarray

Identifiers

PMID26045981
PMCPMC4449430
OpenAlexW2412437999

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.